Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study.

[1]  D. Frappaz,et al.  Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  T. Pietsch,et al.  Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. , 2005, The New England journal of medicine.

[3]  D. Ellison,et al.  Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy. , 2005, European journal of cancer.

[4]  C. Sainte-Rose,et al.  Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage. , 2004, Journal of neurosurgery.

[5]  R. Timmerman,et al.  A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. , 2004, International journal of radiation oncology, biology, physics.

[6]  Amar Gajjar,et al.  Late neurocognitive sequelae in survivors of brain tumours in childhood. , 2004, The Lancet. Oncology.

[7]  Amar Gajjar,et al.  Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  J. Grill,et al.  Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol. , 2003, International journal of radiation oncology, biology, physics.

[9]  P. Burger,et al.  Anaplasia and Grading in Medulloblastomas , 2003, Brain pathology.

[10]  R. Krance,et al.  Feasibility of four consecutive high-dose chemotherapy cycles with stem-cell rescue for patients with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor after craniospinal radiotherapy: results of a collaborative study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  W E Reddick,et al.  Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  N. Willich,et al.  Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. , 2000, International journal of radiation oncology, biology, physics.

[13]  J. Habrand,et al.  Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). , 1999, International journal of radiation oncology, biology, physics.

[14]  L. Rorke,et al.  Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  L. Rorke,et al.  Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Prados,et al.  Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. , 1999, International journal of radiation oncology, biology, physics.

[17]  F. Berthold,et al.  Preradiation chemotherapy of children and young adults with malignant brain tumors: Results of the german pilot trial HIT'88/'89. , 1998, Klinische Padiatrie.

[18]  S. Wellek,et al.  Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. , 1995, Medical and pediatric oncology.

[19]  C. Mottolese,et al.  Preirradiation chemotherapy including "eight drugs in 1 day" regimen and high-dose methotrexate in childhood medulloblastoma: results of the M7 French Cooperative Study. , 1995, Journal of neurosurgery.

[20]  A. Gnekow.  Recommendations of the Brain Tumor Subcommittee for the reporting of trials. SIOP Brain Tumor Subcommittee. International Society of Pediatric Oncology. , 1995, Medical and pediatric oncology.

[21]  L. Rorke,et al.  Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  S. Bellman,et al.  Ototoxicity of cisplatinum. , 1991, British Journal of Cancer.

[23]  W. Wara,et al.  The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone. , 1990, Journal of neurosurgery.

[24]  H. Bloom,et al.  Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). , 1990, European journal of cancer.

[25]  R. Mulhern,et al.  Preirradiation cisplatin and etoposide in the treatment of high-risk medulloblastoma and other malignant embryonal tumors of the central nervous system: a phase II study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  E. Kosnik,et al.  Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  E. Housepian,et al.  An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas. , 1969, Radiology.

[28]  P. Barnes,et al.  Outcome for children with high stage medulloblastoma: Results of the pediatric oncology group 9031 , 2000 .

[29]  D. Frappaz,et al.  Cross‐cultural adaptation of a health status classification system in children with cancer. First results of the French adaptation of the Health Utilities Index Marks 2 and 3 , 1999, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[30]  J. Buatti,et al.  Medulloblastoma: time-dose relationship based on a 30-year review. , 1998, International journal of radiation oncology, biology, physics.

[31]  R. Sanford,et al.  Patterns of failure in children with medulloblastoma: effects of preirradiation chemotherapy. , 1997, International journal of radiation oncology, biology, physics.

[32]  E. Sariban,et al.  Carboplatin and VP 16 in medulloblastoma: a phase II Study of the French Society of Pediatric Oncology (SFOP). , 1994, Medical and pediatric oncology.